Form 8-K - Current report:
SEC Accession No. 0001104659-25-066593
Filing Date
2025-07-09
Accepted
2025-07-09 08:08:52
Documents
12
Period of Report
2025-07-09
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2520099d1_8k.htm   iXBRL 8-K 26379
  Complete submission text file 0001104659-25-066593.txt   190754

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA kala-20250709.xsd EX-101.SCH 3008
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE kala-20250709_lab.xml EX-101.LAB 34239
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kala-20250709_pre.xml EX-101.PRE 22354
14 EXTRACTED XBRL INSTANCE DOCUMENT tm2520099d1_8k_htm.xml XML 3566
Mailing Address 1167 MASSACHUSETTS AVENUE ARLINGTON MA 02476
Business Address 1167 MASSACHUSETTS AVENUE ARLINGTON MA 02476 781-996-5252
KALA BIO, Inc. (Filer) CIK: 0001479419 (see all company filings)

EIN.: 270604595 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38150 | Film No.: 251112309
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)